Related Experiment Video

Updated: Jun 13, 2025

Measuring Retinal Vessel Diameter from Mouse Fluorescent Angiography Images
04:04

Measuring Retinal Vessel Diameter from Mouse Fluorescent Angiography Images

Published on: May 19, 2023

578

MITF regulates IDH1, NNT, and a transcriptional program protecting melanoma from reactive oxygen species

Elisabeth Roider1,2,3, Alexandra I T Lakatos4,5,6, Alicia M McConnell7

  • 1Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, USA. Elisabeth.Roider@usb.ch.

Scientific Reports
|September 14, 2024
PubMed

Insights

The microphthalmia-associated transcription factor (MITF) regulates a cellular antioxidant program, enhancing melanoma cell survival by protecting against reactive oxygen species (ROS) damage. This finding highlights MITF's role in melanoma redox homeostasis.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Microphthalmia-associated transcription factor (MITF) is crucial for melanocyte development and function.
  • MITF amplification is implicated in melanoma development and therapeutic resistance.
  • The role of MITF in cellular redox balance and its direct impact on melanoma survival remains incompletely understood.

Purpose of the Study:

  • To investigate the role of MITF in regulating the cellular antioxidant program in melanoma.
  • To determine if MITF-mediated antioxidant defense contributes to melanoma cell survival and protects against reactive oxygen species (ROS).
  • To identify MITF target genes involved in this antioxidant program and their mechanisms of action.

Main Methods:

  • Analysis of MITF expression and its correlation with redox programs in human melanoma cell lines and patient samples.
  • Utilizing a zebrafish melanoma model to assess MITF's in vivo function in mitigating ROS-mediated DNA damage.
  • Employing functional experiments and gene expression analysis to identify and validate MITF target genes (e.g., IDH1, NNT) and their role in ROS reduction.

Main Results:

  • MITF was found to regulate a global antioxidant program that enhances melanoma cell line survival by protecting against ROS-induced damage.
  • This MITF-driven redox program positively correlated with MITF expression levels in both melanoma cell lines and patient samples.
  • In vivo studies using a zebrafish model demonstrated that MITF effectively reduces ROS-mediated DNA damage.
  • Specific MITF target genes, including IDH1 and NNT, were identified as being directly regulated by MITF binding to enhancer elements and contribute to reducing both cytosolic and mitochondrial ROS.

Conclusions:

  • MITF is a significant regulator of the cellular antioxidant state in melanoma.
  • MITF's ability to control redox homeostasis contributes to melanoma cell survival and potentially influences therapeutic outcomes.
  • Targeting MITF or its downstream antioxidant pathways may represent a novel therapeutic strategy for melanoma treatment.

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

8.7K
Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research06:25

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Published on: March 29, 2024

808

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
12.2K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K